Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APOBEC3A | P31941 | 2/20 | 0.51 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL11236140 | 0.91 | APOBEC3A (0.47) | APOBEC3AAPOBEC3GALDH1A1LMNAPOLB | |
| SCHEMBL15012545 | 0.83 | APOBEC3A (0.40) | APOBEC3AAPOBEC3GALDH1A1LMNAPOLB | |
| Phenylethyl Alcohol SCHEMBL8037469 | 0.83 | TDP1 (0.46) | APOBEC3AAPOBEC3GALDH1A1LMNAPOLB | |
| SCHEMBL15129984 | 0.81 | APOBEC3A (0.46) | APOBEC3AAPOBEC3GALDH1A1LMNAPOLB | |
| SCHEMBL15129812 | 0.77 | APOBEC3A (0.48) | APOBEC3AAPOBEC3GALDH1A1LMNAPOLB | |
| SCHEMBL19814307 | 0.77 | APOBEC3A (0.36) | APOBEC3AAPOBEC3GALDH1A1LMNAPOLB | |
| SCHEMBL13050678 | 0.76 | APOBEC3A (0.32) | APOBEC3AAPOBEC3G | |
| SCHEMBL16210192 | 0.76 | APOBEC3A (0.45) | APOBEC3AAPOBEC3GALDH1A1LMNAPOLB | |
| SCHEMBL11238961 | 0.74 | APOBEC3A (0.46) | APOBEC3AAPOBEC3GALDH1A1LMNAPOLB | |
| SCHEMBL717531 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 593 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4711010-A2 | PRO-PERFUME COMPOSITIONS | Firmenich SA (CH) | 2026-03-18 | — | — | EP | claimed |
| US-12509482-B2 | 3′-ketoglycoside compound for the slow release of a volatile alcohol | GLYCOSCIENCE, S.L. (ES) | 2025-12-30 | — | — | US | claimed |
| US-20250134790-A1 | ANTIMICROBIAL COMPOSITIONS | FIRMENICH SA (CH) | 2025-05-01 | — | — | US | claimed |
| CN-115427421-B | 3' -Ketoglycoside compounds for slow release of volatile alcohols | 格莱克科学有限公司 | 2025-04-01 | — | — | CN | claimed |
| US-12234253-B2 | Silicone compounds with a substituted amine group and a benefit agent moiety | THE PROCTER & GAMBLE COMPANY (US) | 2025-02-25 | — | — | US | claimed |
| US-20250051370-A1 | SILICONE COMPOUNDS | PROCTER & GAMBLE (US) | 2025-02-13 | — | — | US | claimed |
| CN-119403908-A | Method for enhancing psychological performance and composition for use in the method | 弗门尼舍有限公司 | 2025-02-07 | — | — | CN | claimed |
| EP-4387583-A1 | ANTIMICROBIAL COMPOSITIONS | Firmenich SA (CH) | 2024-06-26 | — | — | EP | claimed |
| CN-117881386-A | Antimicrobial compositions | 弗门尼舍有限公司 | 2024-04-12 | — | — | CN | claimed |
| US-20230183284-A1 | 3'-KETOGLYCOSIDE COMPOUND FOR THE SLOW RELEASE OF A VOLATILE ALCOHOL | GLYCOSCIENCE, S.L. (ES) | 2023-06-15 | — | — | US | claimed |
| CN-1233947-A | Fragrance delivery system | PROCTER & GAMBLE (US) | 1999-11-03 | — | — | CN | claimed |
| EP-0951274-A1 | FRAGRANCE DELIVERY SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 1999-10-27 | — | — | EP | claimed |
| EP-0927238-A2 | RINSE ADDED FABRIC SOFTENING COMPOSITIONS AND METHOD OF USE FOR THE DELIVERY OF FRAGRANCE DERIVATIVES | THE PROCTER & GAMBLE COMPANY (US) | 1999-07-07 | — | — | EP | claimed |
| US-5919752-A | ORTHOESTERS, KETALS, ACETALS, ORTHOCARBONATES WHICH RELEASE TWO OR MORE FRAGRANCE RAW MATERIALS UPON HYDROLYSIS. | PROCTER & GAMBLE (US) | 1999-07-06 | — | — | US | claimed |
| WO-1998058899-A1 | FRAGRANCE PRECURSOR COMPOUNDS | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 1998-12-30 | — | — | WO | claimed |
| EP-0878497-A2 | Fragrance precursor compounds | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 1998-11-18 | — | — | EP | claimed |
| WO-1998047996-A1 | LAUNDRY DETERGENT COMPOSITIONS COMPRISING FRAGRANCE PRO-ACCORDS | THE PROCTER & GAMBLE COMPANY (US) | 1998-10-29 | — | — | WO | claimed |
| WO-1998007811-A2 | RINSE ADDED FABRIC SOFTENING COMPOSITIONS AND METHOD OF USE FOR THE DELIVERY OF FRAGRANCE DERIVATIVES | THE PROCTER & GAMBLE COMPANY (US) | 1998-02-26 | — | — | WO | claimed |
| WO-1998007405-A1 | FRAGRANCE DELIVERY SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 1998-02-26 | — | — | WO | claimed |
| US-4321164-A | 2,4,6-Trimethylcyclohexanemethanol and derivatives, process for preparing same and organoleptic uses thereof | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1982-03-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250051370-A1 | SILICONE COMPOUNDS | SMCHD1, SRI, SMS | APOBEC3A 3049/4885APOBEC3G 2483/4885ALDH1A1 3917/4885 |
| US-20230183284-A1 | 3'-KETOGLYCOSIDE COMPOUND FOR THE SLOW RELEASE OF A VOLATILE ALCOHOL | ADH1C, UGCG, ST6GAL1 | APOBEC3A 3711/4885APOBEC3G 2415/4885ALDH1A1 670/4885 |
| US-12234253-B2 | Silicone compounds with a substituted amine group and a benefit agent moiety | SMS, SRM, AAAS | APOBEC3A 1210/4885APOBEC3G 1016/4885ALDH1A1 3361/4885 |
| US-12509482-B2 | 3′-ketoglycoside compound for the slow release of a volatile alcohol | EBP, MGAT1, MGAT3 | APOBEC3A 4802/4885APOBEC3G 4508/4885ALDH1A1 952/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.